Asia Pacific Pharmaceutical Manufacturing Market Size & Outlook

The pharmaceutical manufacturing market in Asia Pacific is expected to reach a projected revenue of US$ 207,213.6 million by 2030. A compound annual growth rate of 11.4% is expected of Asia Pacific pharmaceutical manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$97,068.5
Forecast, 2030 (US$M)
$207,213.6
CAGR, 2024 - 2030
11.4%
Report Coverage
Asia Pacific

Asia Pacific pharmaceutical manufacturing market, 2018-2030 (US$M)

Asia

Asia Pacific pharmaceutical manufacturing market highlights

  • The Asia Pacific pharmaceutical manufacturing market generated a revenue of USD 97,068.5 million in 2023.
  • The market is expected to grow at a CAGR of 11.4% from 2024 to 2030.
  • In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule type in 2023.
  • Biologics & Biosimilars (Large Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 97,068.5 million
Market revenue in 2030USD 207,213.6 million
Growth rate11.4% (CAGR from 2023 to 2030)
Largest segmentConventional drugs (small molecules)
Fastest growing segmentBiologics & Biosimilars (Large Molecules)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)
Key market players worldwideRoche Holding AG ADR, Novartis AG ADR, GlaxoSmithKline, Pfizer Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson, Sanofi SA, Eli Lilly and Co, AbbVie Inc, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Samsung BioLogics, FUJIFILM Holdings Corp, Lonza Group Ltd, Catalent Inc, Jubilant Pharmova


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 19.3% of the global pharmaceutical manufacturing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 207,213.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical Manufacturing Market Scope

Pharmaceutical manufacturing market segmentation & scope
Monoclonal Antibodies
Vaccines
Cell & Gene Therapy
Others
Conventional Drugs (Small Molecules)
Outsource
In-house
Tablets
Capsules
Injectables
Sprays
Suspensions
Powders
Other Formulations
Oral
Topical
Parenterals
Inhalations
Other Routes of Administration
Cardiovascular Diseases
Pain
Diabetes
Cancer
Respiratory Diseases
Other Diseases
Prescription Medicines
Over-the-counter (OTC) Medicines
Children & Adolescents
Adults
Geriatric
Retail
Non-retail

Pharmaceutical Manufacturing Market Companies

Name Profile # Employees HQ Website

Asia Pacific pharmaceutical manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.


Conventional drugs (small molecules) was the largest segment with a revenue share of 63.48% in 2023. Horizon Databook has segmented the Asia Pacific pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific consists of a blend of developing and developed economies. Increasing healthcare expenditure in the region is anticipated to fuel market growth. The increasing geriatric population and rising awareness of dry eye syndrome are among the major factors driving the market in this region.

Asia Pacific’s pharmaceutical industry has witnessed multiple developments primarily targeted toward improving productivity, conducting R&D, and utilizing novel health technologies to their highest potential. 

Most governments are actively working to address recent dynamic changes in the pharmaceutical manufacturing industry caused by the COVID-19 pandemic by organizing virtual conferences. For instance, a virtual conference was held by the Parenteral Drug Association (PDA) - Asia Pacific in September 2020.

Reasons to subscribe to Asia Pacific pharmaceutical manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific pharmaceutical manufacturing market databook

  • Our clientele includes a mix of pharmaceutical manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific pharmaceutical manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific pharmaceutical manufacturing market size, by country, 2018-2030 (US$M)

Asia Pacific Pharmaceutical Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific pharmaceutical manufacturing market size, by country, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more